Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 3/20 | 0.53 |
| ▸ | NAAA | Q02083 | 2/20 | 0.51 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.48 |
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.45 |
| ▸ | MMP9 | P14780 | 2/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15093938 | 0.98 | TACR3 (0.55) | TACR3NAAACNR2POLBEPHX2 | |
| SCHEMBL15093649 | 0.98 | TACR3 (0.55) | TACR3NAAACNR2POLBEPHX2 | |
| SCHEMBL15093655 | 0.98 | TACR3 (0.55) | TACR3NAAACNR2POLBEPHX2 | |
| SCHEMBL15093823 | 0.98 | TACR3 (0.55) | TACR3NAAACNR2POLBEPHX2 | |
| SCHEMBL15093398 | 0.95 | POLB (0.56) | TACR3NAAACNR2POLBEPHX2 | |
| SCHEMBL2021993 | 0.90 | TACR3 (0.53) | TACR3NAAACNR2POLBNPSR1 | |
| SCHEMBL2024979 | 0.89 | TACR3 (0.55) | TACR3NAAACNR2POLBNPSR1 | |
| SCHEMBL2021335 | 0.89 | TACR3 (0.55) | TACR3NAAACNR2POLBNPSR1 | |
| SCHEMBL15861956 | 0.89 | TACR3 (0.55) | TACR3NAAACNR2POLBNPSR1 | |
| SCHEMBL14063604 | 0.89 | TACR3 (0.55) | TACR3NAAACNR2POLBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2679575-B1 | PROCESS FOR PRODUCING CARBONYL COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2019-04-10 | — | — | EP | disclosed |
| CN-103097348-B | The manufacture method of carbonyl compound | ASAHI KASEI CHEMICALS CORP. (JP) | 2015-10-14 | — | — | CN | disclosed |
| US-8957241-B2 | Method for producing carbonyl compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-20130178645-A1 | Method for Producing Carbonyl Compund | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-11 | — | — | US | disclosed |
| CN-103097348-A | Process for producing carbonyl compounds | ASAHI KASEI CHEMICALS CORP (JP) | 2013-05-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178645-A1 | Method for Producing Carbonyl Compund | CA6, CPS1, C9 | TACR3 3595/4885NAAA 1059/4885CNR2 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.